🇰🇷 SOGROYA in South Korea

SOGROYA (SOMAPACITAN-BECO) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

SOGROYA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in South Korea

Frequently asked questions

Is SOGROYA approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for SOGROYA in South Korea?

NOVO NORDISK INC is the originator. The local marketing authorisation holder may differ — check the official source linked above.